05:54 PM EDT, 07/12/2024 (MT Newswires) -- David Kirn, Director, Chief Executive Officer, on July 10, 2024, sold 12,923 shares in 4d Molecular Therapeutics ( FDMT ) for $290,598. Following the Form 4 filing with the SEC, Kirn has control over a total of 1,059,153 shares of the company, with 1,059,153 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1650648/000095017024083303/xslF345X03/ownership.xml

Price: 27.81, Change: +0.59, Percent Change: +2.17